Search research articles
Contact Us
Filters
Showing results (31-40 of 80) with videos related to
Page
of 8
Sort By:
Cell Death & Disease
|
September 4, 2023
Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications
Jianwen Fang, Yue Lu, Jingyan Zheng, et al.
Breast Cancer (Tokyo, Japan)
|
October 13, 2011
Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer
Peifen Fu, Mutsuko Ibusuki, Yutaka Yamamoto, et al.
Journal of Basic Microbiology
|
July 6, 2013
The US2 protein is involved in the penetration and cell-to-cell spreading of DEV in vitro
Shuangshi Wei, Xiaomei Liu, Bo Ma, et al.
Breast Cancer (Tokyo, Japan)
|
December 6, 2011
Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimens
Mutsuko Ibusuki, Peifen Fu, Satoko Yamamoto, et al.
Cancer
|
November 11, 2023
Chimeric antigen receptor-based immunotherapy in breast cancer: Recent progress in China
Tianze Yu, Yuexin Lu, Jianwen Fang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 25, 2012
Comparison of prognostic values between combined immunohistochemical score of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 and the corresponding gene expression score in breast cancer
Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Satoko Yamamoto, et al.
Oncotarget
|
October 15, 2017
Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway
Jie Pan, Jiaying Shen, Wengong Si, et al.
Breast Cancer (Tokyo, Japan)
|
April 23, 2013
Divisional role of quantitative HER2 testing in breast cancer
Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Peifen Fu, et al.
Oncology Letters
|
May 31, 2018
Bcl-2 promotes metastasis through the epithelial-to-mesenchymal transition in the BCap37 medullary breast cancer cell line
Chengyong Du, Xiaochen Zhang, Minya Yao, et al.
Eclinicalmedicine
|
January 8, 2026
Neoadjuvant tislelizumab plus nab-paclitaxel and carboplatin for triple-negative breast cancer: a multicenter, open-label, phase II cTRIO study
Fei Wang, Xiaopeng Hao, Cuizhi Geng, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 80) with videos related to
Sort By:
Page
of 8
Cell Death & Disease
|
September 4, 2023
Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications
Jianwen Fang, Yue Lu, Jingyan Zheng, et al.
Breast Cancer (Tokyo, Japan)
|
October 13, 2011
Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer
Peifen Fu, Mutsuko Ibusuki, Yutaka Yamamoto, et al.
Journal of Basic Microbiology
|
July 6, 2013
The US2 protein is involved in the penetration and cell-to-cell spreading of DEV in vitro
Shuangshi Wei, Xiaomei Liu, Bo Ma, et al.
Breast Cancer (Tokyo, Japan)
|
December 6, 2011
Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimens
Mutsuko Ibusuki, Peifen Fu, Satoko Yamamoto, et al.
Cancer
|
November 11, 2023
Chimeric antigen receptor-based immunotherapy in breast cancer: Recent progress in China
Tianze Yu, Yuexin Lu, Jianwen Fang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 25, 2012
Comparison of prognostic values between combined immunohistochemical score of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 and the corresponding gene expression score in breast cancer
Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Satoko Yamamoto, et al.
Oncotarget
|
October 15, 2017
Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway
Jie Pan, Jiaying Shen, Wengong Si, et al.
Breast Cancer (Tokyo, Japan)
|
April 23, 2013
Divisional role of quantitative HER2 testing in breast cancer
Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Peifen Fu, et al.
Oncology Letters
|
May 31, 2018
Bcl-2 promotes metastasis through the epithelial-to-mesenchymal transition in the BCap37 medullary breast cancer cell line
Chengyong Du, Xiaochen Zhang, Minya Yao, et al.
Eclinicalmedicine
|
January 8, 2026
Neoadjuvant tislelizumab plus nab-paclitaxel and carboplatin for triple-negative breast cancer: a multicenter, open-label, phase II cTRIO study
Fei Wang, Xiaopeng Hao, Cuizhi Geng, et al.
Page
of 8